Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.

被引：0

作者：

Arbour, Kathryn Cecilia

Rizvi, Hira

Plodkowski, Andrew J.

Halpenny, Darragh

Hellmann, Matthew David

Heller, Glenn

Knezevic, Andrea

Yu, Helena Alexandra

Ladanyi, Marc

Kris, Mark G.

Arcila, Maria E.

Rudin, Charles M.

Lito, Piro

Riely, Gregory J.

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9596

引用

页数：2